This is a non-core endpoint: only basic statistics are computed.
See its core counterpart C3_KIDNEY_CLEAR_CELL_CARCINOMA_EXALLC for full statistics.
Clear cell adenocarcinoma of kidney
C3_KIDNEY_CLEAR_CELL_CARCINOMA
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
1 out of 7 registries used, show all original rules. |
1549 |
4. Check minimum number of eventsNone |
1549 |
5. Include endpointsNone |
1549 |
6. Filter based on genotype QC (FinnGen only) |
1549 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF9
Similar endpoints
↥List of similar endpoints to
Clear cell adenocarcinoma of kidney
based on the number of shared cases.
Similar with more cases:
- Clear cell adenocarcinoma of kidney, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm of kidney, except renal pelvis
- Malignant neoplasm of urinary organs
- Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm of urinary organs, excluding all cancers (controls excluding all cancers)
Similar with less cases:
Case counts by codes
↥Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1549 | 589 | 960 |
| Unadjusted period prevalence (%) | 0.34 | 0.20 | 0.42 |
| Median age at first event (years) | 67.78 | 68.40 | 67.40 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1406
- Matched controls
- 14059
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
317.7
323.0
1067
137
8310/3-C64.9
ICD-O-3
Clear cell adenocarcinoma, NOS, of kidney, NOS
+∞
323.0
1406
*
KAC11
NOMESCO Finland
Total nephrectomy with capsule, transcutaneous
538.5
323.0
413
11
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
3545.4
323.0
1347
87
KAC10
NOMESCO Finland
Total nephrectomy with capsule
142.3
315.4
328
30
B01AB10
ATC
tinzaparin; parenteral
13.6
243.2
459
485
JN4AD
NOMESCO Finland
Body CT examination
10.9
233.7
502
682
C64
ICD-10 Finland
Malignant neoplasm of kidney, except renal pelvis
118.1
213.6
228
23
KAD01
NOMESCO Finland
Percutaneous endoscopic partial nephrectomy
153.1
211.3
220
17
KAD00
NOMESCO Finland
Partial nephrectomy
116.1
194.3
208
21
197
Kela drug reimbursment
Sunitinib
178.3
180.5
186
12
WX302
NOMESCO Finland
Thoracal epidural anesthesy
12.5
178.3
343
354
TPH07
NOMESCO Finland
Cathetrisation of artery
7.3
169.8
474
919
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
10.9
166.8
344
404
JN4CD
NOMESCO Finland
Very extensive body CT
13.5
166.3
306
284
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
6.4
158.7
491
1081
JN4BD
NOMESCO Finland
Extensive body CT
6.5
151.6
462
988
L01XE04
ATC
[U] sunitinib; oral
154.0
132.9
139
10
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
29.0
128.3
176
69
1502
Kela drug reimbursment
Cabozantinib
339.2
123.4
123
*
130
Kela drug reimbursment
Malignant tumour
6.4
123.1
367
737
3012
Kela drug reimbursment
Cabozantinib
323.6
118.1
118
*
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
35.5
113.0
147
46
B01AB05
ATC
enoxaparin; parenteral
3.7
111.1
718
3096
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
19.5
108.3
168
97
WX408
NOMESCO Finland
General anesthesy, balanced
3.7
107.3
657
2688
159
Kela drug reimbursment
Pazopanib
210.4
95.7
98
5
WX402
NOMESCO Finland
General anaesthesia
4.0
88.2
423
1357
L01XE26
ATC
[U] cabozantinib; oral
800.9
78.1
76
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
8.5
77.3
178
235
U75
ICPC
Malignant neoplasm of kidney
267.5
75.2
76
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.8
74.8
870
5120
L01EX07
ATC
cabozantinib; oral
370.3
71.3
71
*
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
7.8
67.9
165
236
322
Kela drug reimbursment
Sunitinib
183.9
67.7
70
*
N02BE01
ATC
paracetamol; systemic, rectal
4.6
63.8
1315
10659
L01XE11
ATC
[U] pazopanib; oral
140.5
63.4
67
5
WF049
NOMESCO Finland
Radiotherapy of metastasis
7.3
58.1
147
222
N02AX02
ATC
tramadol; systemic, rectal
2.5
56.7
767
4597
WZC30
NOMESCO Finland
Teaching
3.3
56.5
334
1208
KAC00
NOMESCO Finland
Nephrectomy
49.8
51.5
62
13
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.4
50.7
592
3222
JN3AD
NOMESCO Finland
Abdominal CT examination
3.8
45.5
209
611
158
Kela drug reimbursment
Everolimus
92.9
41.0
45
5
TPH04
NOMESCO Finland
Cathetrisation of vein
2.5
40.9
409
2001
168
Kela drug reimbursment
Axitinib
408.7
40.3
40
*
KAC01
NOMESCO Finland
Percutaneous endoscopic nephrectomy
408.7
40.3
40
*
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
15.7
40.0
66
44
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
5.0
37.7
127
273
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.4
36.6
367
1781
R4110
NOMESCO Finland
Physiotherapy
2.2
36.5
482
2675
C64.80
ICD-10 Finland
Wilms tumour
130.1
35.9
38
*
N02AA05
ATC
oxycodone; systemic
2.6
35.8
299
1310
XX3DW
NOMESCO Finland
Time consuming IT work
2.9
35.5
239
919
KA3LT
NOMESCO Finland
Njurlesion coagulation
68.5
35.1
40
6
WX704
NOMESCO Finland
Intubation
3.6
34.2
165
497
KA1AE
NOMESCO Finland
Kidney ultrasound examination
5.6
33.6
101
190
R31
ICD-10 Finland
Unspecified haematuria
2.8
33.5
237
936
S18
ICPC
Laceration/cut
2.0
31.9
702
4738
343
Kela drug reimbursment
Pazopanib
116.0
31.8
34
*
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
3.6
31.5
153
463
C08CA01
ATC
amlodipine; oral
2.0
30.9
632
4132
WX110
NOMESCO Finland
Local anesthesy
2.0
30.2
969
7454
A03FA01
ATC
metoclopramide; systemic, rectal
2.3
29.9
344
1763
Z51.5
ICD-10 Finland
Palliative care
3.4
29.8
154
489
L01EX01
ATC
sunitinib; oral
158.3
29.8
31
*
L01XE10
ATC
[U] everolimus; oral
81.9
28.8
32
*
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
5.9
28.7
83
149
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.0
28.7
185
686
U14
ICPC
Kidney symptom/complaint
8.7
28.4
62
74
L01XE17
ATC
[U] axitinib; oral
286.9
27.8
28
*
WD515
NOMESCO Finland
Demanding therapy of malignancy with enzyme inhibitors and similar treatments
26.0
27.6
38
15
I10
ICD-10 Finland
Essential (primary) hypertension
1.9
27.0
951
7391
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.2
26.2
298
1504
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
6.4
26.2
70
114
D41.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Renal pelvis
31.6
26.0
34
11
KH1CD
NOMESCO Finland
Very extensive urinary tract ultrasound examination
9.0
25.9
55
63
UKC02
NOMESCO Finland
Cystoscopy
2.1
25.6
327
1737
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
3.1
24.2
138
470
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
10.3
22.9
45
45
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.5
22.9
203
904
WX725
NOMESCO Finland
Noninvasive ventilation
3.6
22.3
104
304
N18.8
ICD-10 Finland
Other chronic renal failure
4.3
21.5
81
196
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
3.2
21.2
116
383
GDB11
NOMESCO Finland
Thoracoscopic wedge resection of lung
12.8
19.9
35
28
361
Kela drug reimbursment
Axitinib
202.7
19.6
20
*
ZXA05
NOMESCO Finland
Left side
1.8
19.5
408
2579
PHN71
NOMESCO Finland
Excision of tumor mass from inferior vena cava
+∞
18.8
18
*
PHE70
NOMESCO Finland
Thrombectomy of inferior vena cava
+∞
18.8
18
*
340
Kela drug reimbursment
Everolimus
101.4
18.6
20
*
JN3KE
NOMESCO Finland
Abdominal ultrasound with added contrast
12.0
18.3
33
28
BCA30
NOMESCO Finland
Unilateral adrenalectomy
25.4
18.2
25
10
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
2.8
18.1
123
469
JN1CD
NOMESCO Finland
Very extensive CT examination of upper part of abdomen
9.2
17.9
37
41
SPAT1153
SPAT
Removal of sutures
1.7
17.8
503
3472
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
2.8
17.8
119
447
PJD43
NOMESCO Finland
Excision of aortic lymph nodes
67.5
17.7
20
*
GD1AD
NOMESCO Finland
Thorax CT examination
3.1
17.7
102
349
D30.0
ICD-10 Finland
Benign neoplasm: Kidney
9.4
17.2
35
38
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
5.5
17.2
51
96
KA4AT
NOMESCO Finland
Cytology of kidney with ultrasound guidance
40.6
16.3
20
5
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
6.3
15.5
41
67
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.1
15.4
182
922
R93.4
ICD-10 Finland
Abnormal findings on diagnostic imaging of urinary organs
9.3
15.2
31
34
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
3.0
14.9
87
302
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
4.5
14.7
52
119
L01EX03
ATC
pazopanib; oral
+∞
14.6
14
*
TK800
NOMESCO Finland
Hemodialysis
3.9
14.1
57
149
C03CA01
ATC
furosemide; systemic
1.6
14.0
431
2996
ZXA00
NOMESCO Finland
Right side
1.6
13.7
407
2800
L01EK01
ATC
axitinib; oral
+∞
13.6
13
*
PC5DT
NOMESCO Finland
Embolisation of tumor of kidney
+∞
13.6
13
*
JN1BD
NOMESCO Finland
Extensive CT examination of upper part of abdomen
7.3
13.3
31
43
ZXC96
NOMESCO Finland
Robot assisted procedure
3.2
13.2
68
217
WX290
NOMESCO Finland
Other blockade of nerve
1.6
12.6
497
3658
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
7.4
12.5
29
40
Z85.5
ICD-10 Finland
Personal history of malignant neoplasm of urinary tract
131.1
12.5
13
*
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
2.5
12.3
98
410
A02BC02
ATC
pantoprazole; systemic
1.5
12.3
885
7438
N28.1
ICD-10 Finland
Cyst of kidney
4.9
12.2
39
81
M05BX04
ATC
denosumab; parenteral
2.7
12.2
85
331
C65
ICD-10 Finland
Malignant neoplasm of renal pelvis
16.0
12.1
19
12
ZX120
NOMESCO Finland
Intravenous
2.1
12.0
145
739
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.7
11.6
255
1600
A11CC03
ATC
alfacalcidol; systemic
3.8
11.6
49
134
V03AE01
ATC
polystyrene sulfonate; oral
5.1
11.4
35
70
H02AB02
ATC
dexamethasone; systemic
2.0
11.2
149
788
C79.7
ICD-10 Finland
Secondary malignant neoplasm of adrenal gland
20.2
11.1
16
8
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
3.7
11.1
47
129
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
2.4
11.1
93
401
KH1AD
NOMESCO Finland
CT of urinary organs
2.9
11.0
68
246
198
Kela drug reimbursment
Sorafenib
12.0
10.8
19
16
L01XE05
ATC
[U] sorafenib; oral
21.6
10.7
15
7
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
1.9
10.7
164
917
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
2.7
10.6
70
264
JN3DG
NOMESCO Finland
Very extensive MRI examination with high intensity magnet
14.3
10.5
17
12
A10BH05
ATC
linagliptin; oral
2.4
10.2
90
397
WX306
NOMESCO Finland
Lumbar epidural anesthesy
2.8
10.2
64
235
AA1BD
NOMESCO Finland
Extensive CT of head and brain
3.2
10.1
52
167
BCA31
NOMESCO Finland
Endoscopic unilateral adrenalectomy
9.2
10.0
20
22
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.7
9.8
237
1526
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
3.2
9.8
50
160
N02AJ06
ATC
codeine and paracetamol; systemic
1.5
9.7
479
3656
205
Kela drug reimbursment
Chronic hypertension
1.5
9.6
431
3221
D44.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Adrenal gland
4.3
9.6
34
80
R50.9
ICD-10 Finland
Fever, unspecified
1.8
9.5
187
1132
M84.4
ICD-10 Finland
Pathological fracture, not elsewhere classified
15.1
9.5
15
10
KB1CG
NOMESCO Finland
Extensive MRI examination of urinary tract with high intensity magnet
100.7
9.4
10
*
Z90.5
ICD-10 Finland
Acquired absence of kidney
30.2
9.4
12
*
D41
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour of urinary organs
+∞
9.4
9
*
M04AA01
ATC
allopurinol; systemic
1.7
9.4
205
1284
J01DB01
ATC
cefalexin; oral
1.5
9.3
1090
9807
M49.5*C79.5
ICD-10 Finland
Metastatic fracture of vertebra
36.9
9.0
11
*
J01MA02
ATC
ciprofloxacin; systemic
1.4
9.0
532
4189
WW500
NOMESCO Finland
Blood transfusion
2.5
8.9
68
280
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
1.9
8.9
131
719
AA1AD
NOMESCO Finland
CT of head and brain
1.5
8.9
352
2556
RJ128
NOMESCO Finland
NA
12.6
8.9
15
12
WX892
NOMESCO Finland
Monitored bed care
1.9
8.8
121
652
WF004
NOMESCO Finland
Palliative radiotherapy
3.3
8.6
42
131
JAD30
NOMESCO Finland
Repair of incisional hernia using prosthetic material
3.8
8.6
34
90
C77.2
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes
10.1
8.5
16
16
E89.6
ICD-10 Finland
Postprocedural adrenocortical(-medullary) hypofunction
90.6
8.4
9
*
R4190
NOMESCO Finland
Nutritional therapy
2.9
8.3
48
168
C78.8
ICD-10 Finland
Secondary malignant neoplasm of other and unspecified digestive organs
9.5
8.3
16
17
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
4.0
8.2
31
79
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
3.2
8.1
41
132
U06
ICPC
Haematuria
2.9
8.1
47
165
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
3.0
8.1
44
149
N17.9
ICD-10 Finland
Acute renal failure, unspecified
2.4
8.1
66
284
NK6AN
NOMESCO Finland
Total body bone isotope imaging
2.7
8.0
52
196
105
Kela drug reimbursment
Adrenal cortical hypofunction
22.1
8.0
11
5
WX600
NOMESCO Finland
Single shot through catheter
5.7
7.8
21
37
B01AB04
ATC
dalteparin; parenteral
2.2
7.8
79
375
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
3.9
7.8
30
78
D64.9
ICD-10 Finland
Anaemia, unspecified
1.8
7.8
145
866
WX002
NOMESCO Finland
Sedation and analgesia
1.5
7.7
269
1891
A04AA02
ATC
granisetron; systemic, transdermal
2.1
7.7
83
406
H02AB09
ATC
hydrocortisone; systemic
3.2
7.6
38
122
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
2.7
7.5
48
179
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.7
7.5
141
843
1XC17
NOMESCO Finland
NA
+∞
7.3
7
*
A79
ICPC
Malignancy NOS
4.0
7.2
27
69
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.7
7.1
160
1006
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
1.5
7.0
227
1567
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.4
7.0
398
3079
YX8BD
NOMESCO Finland
Stereotactic extensive CT examination for dose design of radiotherapy
7.6
6.9
15
20
N18.0
ICD-10 Finland
End-stage renal disease
4.1
6.9
25
62
JAD11
NOMESCO Finland
Laparoscopic repair of incisional hernia
4.4
6.8
23
53
N03AX16
ATC
pregabalin; oral
1.5
6.8
292
2142
Z49.0
ICD-10 Finland
Preparatory care for dialysis
4.3
6.7
23
54
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.7
6.7
151
951
N99.0
ICD-10 Finland
Postprocedural renal failure
22.6
6.7
9
*
A06AH03
ATC
naloxegol; oral
4.5
6.7
22
50
E0000UV
ATC
NA
1.4
6.6
463
3709
SPAT1254
SPAT
Administration of medicine
1.6
6.6
188
1257
AAB00
NOMESCO Finland
Extirpation of intracranial lesion
4.1
6.6
24
60
G04CA02
ATC
tamsulosin; oral
1.4
6.6
380
2946
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
2.0
6.5
85
448
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
1.9
6.5
97
540
E87.5
ICD-10 Finland
Hyperkalaemia
3.2
6.4
31
98
L01EG02
ATC
everolimus; oral (mammalian target of rapamycin kinase inhibitors (mtor))
70.1
6.4
7
*
PHN70
NOMESCO Finland
Plastic repair of inferior vena cava
70.1
6.4
7
*
M907, C6488
ICD-10 Finland
NA
70.1
6.4
7
*
C02AC05
ATC
moxonidine; oral
2.0
6.4
72
361
J01MA12
ATC
levofloxacin; systemic
1.5
6.4
253
1828
C77.1
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes
8.2
6.3
13
16
C79.0
ICD-10 Finland
Secondary malignant neoplasm of kidney and renal pelvis
18.1
6.3
9
5
K46.9
ICD-10 Finland
Unspecified abdominal hernia without obstruction or gangrene
7.1
6.2
14
20
N18.5
ICD-10 Finland
Chronic kidney disease, stage 5
8.6
6.1
12
14
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
3.1
6.0
31
103
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
1163
6419
4.26
141.33
5.1
4.2
—
—
—
0
0
351
858
5.00
136.90
7.1
10.9
—
—
—
0
0
1100
6154
3.72
123.61
8.3
5.0
34.5
35.0
g/l
2.26
1047
5722
450
1525
3.75
111.11
7.0
8.7
120.5
121.8
g/l
0.66
439
1469
472
1658
3.66
110.30
6.8
8.2
96.8
95.5
%
6.81
457
1601
1112
6523
3.50
110.09
9.3
6.4
1.2
1.2
mmol/l
0.55
1054
5886
1331
8775
4.67
109.79
5.9
4.6
914.1
1909.0
e6/l
0.42
14
146
486
1773
3.54
106.67
4.5
4.2
224.4
250.2
u/l
3.32
476
1680
494
1830
3.50
105.72
6.7
7.8
-0.1
1.1
mmol/l
9.91
398
1418
492
1832
3.47
104.24
6.8
7.8
5.3
5.1
kpa
6.22
476
1746
491
1833
3.46
103.51
6.7
7.8
13.9
11.9
kpa
11.48
475
1749
839
4315
3.06
101.46
4.8
3.4
78.3
88.9
e6/l
0.16
718
3375
1139
7077
3.30
96.12
10.9
7.3
1.2
1.2
mmol/l
1.06
949
5972
1163
7322
3.36
95.78
12.9
6.4
10.8
12.0
umol/l
2.89
1127
6971
405
1405
3.55
94.93
7.8
7.4
11.0
10.3
mmol/l
1.12
386
1335
1253
8288
3.68
94.24
7.2
5.2
6.9
6.9
mmol/l
0.31
1217
7826
775
3948
2.93
93.09
4.5
3.2
0.4
0.5
e6/l
0.14
653
3023
1440
10561
6.17
91.34
15.8
7.9
81.9
79.5
u/l
1.36
1418
9933
283
824
3.98
85.35
7.8
10.1
23.5
24.3
mmol/l
4.48
274
766
1012
6140
2.87
84.04
10.9
10.6
1.2
1.3
inr
3.81
301
1680
478
1986
3.03
81.49
8.4
7.0
104.7
104.3
mmol/l
1.81
469
1928
621
3001
2.78
79.51
3.4
2.6
4.0
4.6
e6/l
0.95
561
2662
767
4368
2.50
67.12
4.7
2.6
67.5
57.7
u/l
1.35
728
4030
1127
7730
2.68
65.12
15.1
9.2
4.3
4.2
e9/l
0.21
997
6761
646
3439
2.51
64.91
2.7
2.5
—
—
—
0
0
289
1015
3.27
64.35
8.4
9.5
95.4
94.0
%
9.51
289
1008
288
1013
3.26
63.95
8.2
9.4
0.5
0.7
%
16.51
288
1005
445
1996
2.73
63.58
7.9
6.1
1.1
1.0
mmol/l
1.57
423
1845
289
1022
3.25
63.57
8.1
9.3
0.9
1.4
%
10.99
289
1015
341
1344
2.97
62.04
7.4
7.3
1.2
1.4
mmol/l
5.24
333
1295
488
2319
2.61
61.81
4.2
3.1
2.0
1.6
e6/l
0.56
319
1304
498
2406
2.58
60.78
4.5
3.4
0.8
0.8
mmol/l
0.27
476
2255
786
4676
2.38
60.43
7.5
3.4
2.4
2.4
mmol/l
1.45
725
4021
490
2488
2.42
52.46
4.0
2.9
0.8
1.1
e6/l
1.20
319
1464
286
1147
2.83
49.51
5.9
2.1
384.8
370.0
nmol/l
0.61
277
1050
452
2328
2.33
45.88
2.2
2.0
29.9
30.0
s
0.15
447
2256
689
4235
2.13
44.79
5.1
3.2
31.0
38.9
u/l
1.29
660
4023
484
2660
2.19
41.28
6.9
3.1
2.5
2.5
mmol/l
2.94
455
2340
128
366
3.72
38.58
5.5
8.2
105.8
105.6
mmol/l
0.34
118
328
421
2279
2.16
36.64
3.2
2.6
11.0
12.8
umol/l
4.88
397
2118
382
2020
2.18
35.09
3.3
2.6
20.5
22.8
%
2.30
323
1716
395
2126
2.15
34.63
3.2
2.6
2.1
2.3
g/l
7.31
375
1975
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
160
574
2.99
33.38
3.0
2.6
0.4
0.3
u/ml
0.68
72
334
1467
12945
3.52
30.06
27.5
16.2
35.4
26.2
mg/l
17.31
1399
10464
873
6395
1.84
29.43
4.8
3.8
0.0
0.0
estimate
0.00
218
1193
1205
9820
2.02
28.77
4.8
4.2
18.7
13.1
mm/h
14.79
1121
9029
166
662
2.69
28.30
5.3
6.0
1.8
1.6
%
1.49
155
621
294
1520
2.15
27.95
4.1
3.6
—
—
—
0
0
873
6476
1.80
27.41
4.8
3.8
0.0
0.0
estimate
0.37
218
1148
84
237
3.69
25.74
1.5
1.3
15.3
7.8
u/l
3.18
68
189
291
1543
2.09
25.72
3.1
2.8
7.4
8.8
umol/l
0.62
263
1380
69
169
4.23
25.72
1.4
1.3
0.2
0.4
nmol/l
—
7
17
227
1106
2.23
24.84
5.6
3.9
129.7
95.7
ng/l
3.39
202
960
853
6399
1.74
24.67
6.7
5.1
0.0
0.0
estimate
0.00
227
1209
404
2434
1.89
24.64
1.9
1.9
—
—
—
0
0
215
1031
2.26
24.43
6.3
7.4
24.2
24.5
mmol/l
0.67
203
961
66
166
4.11
23.76
1.5
1.4
30.8
31.2
iu/l
0.03
47
136
160
702
2.43
22.23
6.1
4.0
23.8
24.2
mmol/l
0.76
152
618
264
1423
2.03
22.06
5.8
3.7
1.5
2.0
mmol/l
1.17
219
1122
228
1167
2.12
21.89
6.6
4.1
1.2
1.2
mmol/l
0.96
211
1023
263
1425
2.02
21.63
5.8
3.7
6.0
5.8
kpa
1.71
257
1378
245
1300
2.05
21.33
3.1
2.9
65.9
66.4
g/l
0.39
226
1192
24
25
9.74
20.59
11.7
2.0
52.8
40.9
u/l
—
14
8
306
1794
1.88
19.81
2.5
2.6
1.8
1.8
%
0.20
280
1591
1489
13722
3.20
19.04
35.9
19.2
139.0
139.7
mmol/l
20.01
1484
13380
1490
13759
3.18
18.53
36.2
19.3
4.1
4.0
mmol/l
26.51
1484
13396
732
5574
1.59
17.61
4.6
3.9
40.8
57.8
ng/l
0.97
595
4214
635
4677
1.61
17.56
3.4
3.2
7.3
7.6
mmol/l
1.15
518
3887
75
252
3.08
17.47
1.4
1.8
2.1
5.0
iu/l
3.46
18
89
270
1590
1.85
17.02
3.2
4.2
9.8
20.2
ug/l
0.67
218
1327
199
1061
2.00
16.91
1.8
1.6
—
—
—
0
0
504
3555
1.62
16.40
2.3
2.2
3.2
3.1
mg/l
0.49
434
3027
1120
9537
1.63
15.97
7.4
3.7
15.1
15.0
pmol/l
0.85
1022
8510
644
4836
1.57
15.95
4.2
4.1
24.2
8.5
mg/mmol
5.02
409
3129
125
570
2.30
15.84
3.0
3.5
1356.1
2582.1
u/ml
0.24
110
490
224
1272
1.89
15.76
3.3
2.4
37.2
40.4
u/l
0.28
201
1091
1489
13874
2.89
15.69
38.9
19.3
109.2
82.6
umol/l
46.76
1489
13868
1205
10481
1.67
15.47
37.8
19.9
14.3
13.8
%
18.77
1198
10239
649
4908
1.55
15.43
5.4
4.1
—
—
—
0
0
240
1410
1.83
15.13
1.9
2.2
0.2
0.2
g/l
0.29
228
1320
91
370
2.55
14.84
2.6
2.9
1.9
1.7
mg/l
1.75
82
332
1309
11705
1.76
14.44
8.0
4.6
2.2
2.1
mu/l
0.34
1212
10522
276
1712
1.74
14.44
1.8
1.8
—
—
—
0
0
673
5183
1.53
14.43
3.4
2.8
215.3
164.0
ug/l
2.90
606
4703
147
748
2.07
14.14
1.6
1.8
1.8
1.6
g/l
1.58
124
651
275
1716
1.73
14.06
1.8
1.8
—
—
—
0
0
130
634
2.15
13.97
4.9
3.3
4.3
4.4
pmol/l
0.54
120
557
177
968
1.94
13.89
4.7
3.6
1.4
1.9
mmol/l
0.92
124
728
229
1368
1.79
13.59
2.9
2.7
69.8
70.2
e9/l
0.05
170
1062
520
3834
1.54
13.38
3.2
2.9
2327.1
6220.6
umol/l
1.71
450
3302
406
2834
1.59
13.31
5.0
4.0
2447.2
431.6
ng/l
0.47
351
2371
84
350
2.48
13.03
1.3
1.2
—
—
—
0
0
181
1025
1.87
12.75
4.7
3.6
5.1
5.1
kpa
0.12
168
948
80
334
2.47
12.37
3.1
2.6
16.6
16.1
%
0.39
49
172
58
211
2.82
11.79
1.4
1.5
1294.3
1626.2
e6/l
0.51
39
152
83
361
2.37
11.74
3.0
3.0
8.0
7.9
kpa
0.07
78
327
1259
11372
1.57
10.70
32.0
17.5
38.1
39.6
%
5.10
799
7460
1469
13860
2.16
10.53
18.6
11.3
27.5
26.9
u/l
0.27
1441
13341
77
342
2.32
10.41
1.3
1.5
—
—
—
0
0
391
2842
1.50
10.28
1.7
1.7
1.8
1.4
mg/l
1.27
329
2226
125
676
1.92
10.11
1.9
1.9
1.0
1.9
ug/l
1.00
113
601
470
3556
1.46
10.07
5.2
4.1
0.0
0.0
estimate
0.16
204
1138
160
942
1.78
9.89
1.9
1.6
—
—
—
0
0
959
8266
1.42
9.84
3.7
3.2
67.7
56.7
u/l
2.11
884
7600
190
1177
1.70
9.81
4.1
2.9
4.6
4.5
kpa
0.18
182
1139
50
187
2.73
9.70
1.3
1.4
34208.6
102334.5
e6/l
0.97
25
109
44
156
2.87
9.43
1.2
1.4
338.6
345.6
u/l
0.03
44
151
1493
14238
2.34
9.38
44.4
23.8
245.0
240.9
e9/l
1.48
1481
13850
559
4413
1.42
9.37
2.1
2.2
256.5
232.0
u/l
0.21
525
4128
1493
14242
2.34
9.30
44.2
23.8
4.4
4.5
e12/l
12.07
1476
13804
1493
14244
2.33
9.26
44.3
23.9
7.2
6.8
e9/l
8.78
1477
13807
86
422
2.10
9.14
1.9
1.7
—
—
—
0
0
1342
12413
1.61
9.11
32.5
15.2
62.2
76.5
ml/min/173m2
94.45
1240
10304
86
423
2.09
9.08
3.5
3.2
23.8
25.0
mmol/l
1.92
79
365
66
295
2.29
8.83
3.2
5.8
1362.3
768.4
iu/ml
—
8
46
574
4606
1.39
8.55
3.1
3.1
1914.6
1455.0
ng/l
1.26
515
3976
58
249
2.38
8.51
3.8
3.2
4.5
4.4
e9/l
0.19
58
249
28
81
3.50
8.39
1.9
2.3
15.2
15.2
%
—
6
29
19
41
4.68
8.36
2.1
2.1
—
—
—
0
0
27
77
3.55
8.26
2.0
2.3
—
—
—
0
0
59
262
2.30
8.04
3.9
3.5
59.6
58.9
%
0.16
59
262
41
155
2.69
7.84
1.3
1.4
230.0
295.4
pmol/l
0.87
33
120
448
3499
1.39
7.67
1.6
1.6
18.7
20.4
nmol/l
1.59
389
2936
708
5966
1.34
7.42
2.1
2.0
92.3
94.0
pmol/l
0.42
408
3150
34
121
2.85
7.29
1.2
1.3
10.3
12.8
u/l
0.57
29
112
68
341
2.04
6.89
3.0
2.2
131.7
129.4
g/l
0.29
59
258
107
625
1.76
6.82
1.3
1.2
182.0
139.8
iu/ml
0.33
33
228
23
72
3.23
6.16
2.4
1.9
—
—
—
0
0
48
221
2.21
6.08
1.0
1.1
—
—
—
0
0
764
6627
1.30
6.07
2.6
2.4
—
—
—
0
0
96
564
1.75
6.02
2.2
2.7
—
—
—
0
0
81
453
1.83
5.99
1.3
1.2
—
—
—
0
0
136
878
1.60
5.97
1.6
1.5
—
—
—
0
0
93
547
1.74
5.82
2.1
1.8
—
—
—
0
0
72
397
1.85
5.59
2.4
2.3
178.2
103.1
ug/min
0.54
41
246
16
43
3.75
5.37
1.5
1.3
27.5
28.5
%
0.04
16
32
90
538
1.71
5.34
2.2
3.9
55.4
65.9
mg/l
0.34
68
441
98
605
1.66
5.17
1.5
2.8
4.1
3.8
g/l
1.06
63
442
98
606
1.66
5.14
1.5
2.8
—
—
—
0
0
98
606
1.66
5.14
1.6
2.8
8.2
7.4
g/l
2.20
66
458
29
116
2.53
5.05
1.2
1.4
11.5
13.9
u/l
0.71
29
110
89
539
1.69
5.05
2.2
3.9
117.5
77.0
mg/l
0.26
66
444
617
5293
1.28
5.04
2.5
2.2
79.2
78.0
nmol/l
0.44
561
4648
25
93
2.72
5.02
1.6
1.7
—
—
—
0
0
97
603
1.65
4.99
2.1
2.0
—
—
—
0
0
31
129
2.43
4.98
1.9
2.3
717.8
643.0
ml
0.47
22
81
352
2817
1.32
4.85
1.8
1.8
1087.0
1172.6
nmol/l
1.04
287
2121
92
572
1.65
4.74
1.5
2.8
10.9
10.5
g/l
0.31
72
491
69
402
1.75
4.52
1.3
1.6
—
—
—
0
0
26
105
2.50
4.47
1.2
1.3
—
—
—
0
0
89
561
1.62
4.37
1.6
2.8
3.4
3.1
g/l
1.58
65
449
61
349
1.78
4.27
1.8
2.7
27.8
37.7
umol/l
2.03
44
295
70
423
1.69
4.06
1.3
1.5
239.2
266.7
ug/g
0.57
46
253
14
42
3.35
4.04
1.2
1.2
—
—
—
0
0
183
1365
1.39
3.97
2.9
3.0
282.4
206.6
ng/l
0.81
172
1256
28
125
2.26
3.91
1.1
1.7
—
—
—
0
0
32
152
2.13
3.86
2.2
2.6
—
—
—
0
0
32
155
2.09
3.68
2.4
2.4
—
—
—
0
0
135
1844
0.71
3.66
9.9
7.5
—
—
—
0
0
19
74
2.59
3.55
1.7
1.6
2.7
8.2
u/l
1.33
13
42
10
26
3.86
3.52
4.6
2.8
149.9
3246.4
u/l
—
10
26
59
358
1.67
3.42
1.2
1.8
—
—
—
0
0
253
2035
1.29
3.30
22.9
27.6
1.5
1.4
inr
0.60
37
280
33
171
1.95
3.20
1.1
1.7
—
—
—
0
0
10
28
3.59
3.20
1.0
1.1
—
—
—
0
0
46
267
1.74
3.14
1.3
1.5
—
—
—
0
0
77
514
1.52
3.04
1.8
2.8
1.1
1.3
g/l
0.18
65
449
46
271
1.72
3.00
1.1
1.8
—
—
—
0
0
20
88
2.29
2.94
1.3
1.6
—
—
—
0
0
20
88
2.29
2.94
1.3
1.6
—
—
—
0
0
38
217
1.77
2.78
1.2
1.7
—
—
—
0
0
68
452
1.53
2.76
1.4
2.7
0.0
0.0
g/l
1.36
62
418
41
240
1.73
2.76
1.3
1.5
—
—
—
0
0
18
78
2.32
2.75
1.1
1.1
—
—
—
0
0
71
479
1.51
2.70
1.5
2.6
36.6
37.3
g/l
0.41
61
415
22
105
2.11
2.69
1.2
1.5
—
—
—
0
0
8
19
4.23
2.68
1.0
1.6
2.5
1.9
umol/l
—
8
19
25
126
2.00
2.66
1.3
1.3
—
—
—
0
0
137
1044
1.34
2.65
2.5
2.9
10.6
10.8
g/l
0.25
125
957
13
49
2.67
2.62
1.2
1.3
317.7
85.2
ug/l
—
6
21
58
377
1.56
2.62
1.2
1.7
—
—
—
0
0
27
141
1.93
2.61
1.4
1.4
—
—
—
0
0
64
428
1.52
2.55
1.4
2.7
0.0
0.0
g/l
0.00
59
395
37
216
1.73
2.53
1.3
1.5
—
—
—
0
0
38
224
1.71
2.52
1.9
1.4
113.2
129.7
u/ml
0.29
13
35
333
2855
1.21
2.45
5.4
4.2
1.0
1.0
kg/l
0.17
66
411
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
18
83
2.18
2.41
1.2
1.1
—
—
—
0
0
52
340
1.55
2.32
2.5
3.5
19.7
1141.2
u/ml
0.88
46
319
24
127
1.90
2.26
1.2
1.2
51.4
53.4
u/l
0.09
16
94
15
66
2.29
2.24
2.1
3.8
222.4
211.1
u/l
0.22
15
66
35
213
1.66
2.11
1.2
1.2
—
—
—
0
0
415
3678
1.18
2.09
1.7
1.7
1.6
1.4
mmol/l
4.91
342
3039
22
118
1.88
2.02
1.1
1.1
—
—
—
0
0
46
304
1.53
1.99
1.3
1.4
—
—
—
0
0
46
304
1.53
1.99
1.3
1.4
—
—
—
0
0
38
241
1.59
1.97
1.3
1.1
—
—
—
0
0
713
6605
1.15
1.96
5.1
5.1
2.6
2.8
ug/l
0.43
631
5909
60
840
0.70
1.96
1.9
1.9
—
—
—
0
0
8
27
2.97
1.93
2.1
2.3
1.2
1.2
mmol/l
—
8
27
46
311
1.49
1.82
1.7
1.3
—
—
—
0
0
1332
12949
1.20
1.79
5.8
5.0
6.2
6.1
mmol/l
2.78
1195
11659
10
41
2.45
1.75
1.2
1.1
—
—
—
0
0
10
41
2.45
1.75
1.2
1.1
—
—
—
0
0
157
1292
1.24
1.75
2.9
2.2
359.2
163.1
ug/g
0.74
124
1031
6
18
3.34
1.74
2.2
1.7
252.0
151.9
ng/l
—
6
18
139
1130
1.25
1.72
4.5
2.9
48.5
61.9
ml/min/173m2
6.69
83
457
34
218
1.57
1.71
1.2
1.5
—
—
—
0
0
29
179
1.63
1.70
4.2
6.6
7.0
7.5
mmol/l
0.37
22
148
5
14
3.58
1.61
2.0
2.7
0.0
0.5
u/field
—
5
14
6
21
2.86
1.50
4.3
4.8
—
—
—
0
0
23
139
1.66
1.48
1.9
1.1
—
—
—
0
0
22
132
1.68
1.46
1.6
1.7
—
—
—
0
0
14
73
1.93
1.44
1.4
1.4
—
—
—
0
0
14
73
1.93
1.44
1.1
1.0
—
—
—
0
0
6
22
2.73
1.43
1.2
1.2
—
—
—
0
0
9
40
2.26
1.40
2.2
1.3
14.0
9.4
ug/l
—
9
40
20
120
1.68
1.34
1.1
1.0
—
—
—
0
0
45
325
1.40
1.33
1.7
1.6
—
—
—
0
0
26
168
1.56
1.32
1.2
1.8
—
—
—
0
0
1282
12496
1.15
1.30
6.9
6.4
41.4
40.7
mmol/mol
1.57
1187
11466
44
318
1.39
1.30
1.5
1.7
—
—
—
0
0
14
76
1.85
1.30
2.6
2.4
—
—
—
0
0
14
76
1.85
1.30
2.2
1.4
2.9
5.4
u/field
0.44
14
54
65
504
1.30
1.24
1.4
1.5
112.0
342.6
titre
—
5
23
9
45
2.01
1.23
1.1
1.1
—
—
—
0
0
6
26
2.31
1.18
1.3
1.6
—
—
—
0
0
12
212
0.56
1.18
1.2
1.3
—
—
—
0
0
5
20
2.50
1.15
1.2
1.0
—
—
—
0
0
5
20
2.50
1.15
1.2
1.2
—
—
—
0
0
43
318
1.36
1.14
1.3
1.4
—
—
—
0
0
33
233
1.43
1.13
1.3
1.2
—
—
—
0
0
29
200
1.46
1.12
2.0
2.5
16.5
26.7
mg/l
—
10
49
40
293
1.37
1.12
1.1
1.2
—
414.3
—
0
7
31
218
1.43
1.09
1.3
1.2
225.1
301.0
u/ml
1.04
19
125
272
2458
1.13
1.04
1.2
1.2
2.5
1.7
u/ml
0.21
60
635
9
46
1.96
1.03
1.1
1.1
—
—
—
0
0
54
421
1.29
1.02
1.6
1.4
—
—
—
0
0
23
155
1.49
1.01
1.2
1.8
—
—
—
0
0
12
68
1.77
1.00
1.1
1.2
—
—
—
0
0
9
49
1.84
0.98
2.3
2.7
—
—
—
0
0
9
49
1.84
0.98
2.3
2.7
—
—
—
0
0
337
3100
1.11
0.96
1.7
1.7
46350757.9
31548281.0
pmol/l
0.12
274
2539
20
133
1.51
0.94
1.1
1.1
—
—
—
0
0
7
37
1.90
0.94
9.6
3.1
15.3
15.1
ml/dl
—
7
32
23
325
0.70
0.90
4.1
3.6
36.5
28.1
mg/l
0.41
18
203
47
368
1.29
0.89
1.1
1.2
—
—
—
0
0
12
71
1.70
0.89
1.1
1.3
504.8
440.6
u/l
0.06
12
65
8
42
1.91
0.88
1.1
1.1
—
—
—
0
0
10
56
1.79
0.88
21.2
16.4
1615.2
1432.9
nmol/l
—
10
56
18
120
1.51
0.85
1.8
2.0
5.2
2.2
u/field
—
10
46
31
411
0.75
0.84
1.3
1.8
41.9
41.1
nmol/l
0.06
31
389
46
365
1.27
0.80
1.1
1.2
—
—
—
0
0
15
98
1.54
0.78
1.3
1.2
2.7
2.0
mmol/l
0.72
15
91
27
201
1.35
0.74
2.1
2.4
41.0
282.8
u/ml
0.60
27
194
158
1417
1.13
0.73
1.3
1.3
—
—
—
0
0
5
25
2.00
0.72
1.0
1.9
—
—
—
0
0
12
76
1.58
0.71
1.2
1.4
—
—
—
0
0
12
76
1.58
0.71
1.2
1.4
—
—
—
0
0
7
41
1.71
0.70
1.4
1.1
—
—
—
0
0
22
161
1.37
0.68
3.3
3.9
—
—
—
0
0
42
338
1.25
0.68
2.1
1.6
—
—
—
0
0
60
503
1.20
0.67
5.1
4.0
4.0
4.0
mmol/l
0.15
55
464
5
91
0.55
0.67
1.0
1.1
—
—
—
0
0
5
91
0.55
0.67
1.0
1.1
—
—
—
0
0
5
91
0.55
0.67
1.0
1.1
—
—
—
0
0
40
321
1.25
0.66
5.8
3.5
6.9
7.7
mmol/l
1.68
40
315
11
70
1.58
0.65
1.4
1.0
1.0
1.3
u/l
—
6
39
14
95
1.48
0.64
1.4
1.4
—
—
—
0
0
25
190
1.32
0.63
1.3
1.5
—
—
—
0
0
5
30
1.67
0.61
1.8
1.4
0.4
0.4
ug/l
—
5
18
137
1236
1.12
0.60
2.0
2.2
11.8
13.2
nmol/l
1.31
120
1077
12
80
1.50
0.60
1.2
1.2
—
—
—
0
0
12
80
1.50
0.60
1.2
1.2
—
—
—
0
0
8
52
1.54
0.59
1.4
1.2
—
—
—
0
0
12
173
0.69
0.57
1.2
1.4
—
—
—
0
0
26
202
1.29
0.57
1.0
1.1
1.7
75.9
iu/ml
—
9
37
8
54
1.48
0.57
1.1
2.6
—
47849.3
—
0
10
5
88
0.57
0.56
1.0
1.1
—
—
—
0
0
5
88
0.57
0.56
1.0
1.1
—
—
—
0
0
6
37
1.62
0.55
1.0
1.1
—
—
—
0
0
44
367
1.20
0.54
1.4
2.1
11.6
12.2
mg/l
0.19
39
337
24
186
1.29
0.54
2.0
1.6
81.4
63.1
%
2.51
16
121
11
74
1.49
0.53
1.1
1.1
—
—
—
0
0
9
62
1.45
0.53
1.1
1.2
—
—
—
0
0
6
39
1.54
0.53
1.2
1.1
680.5
1577.7
miu/ml
—
6
39
9
63
1.43
0.52
1.0
2.1
—
—
—
0
0
9
63
1.43
0.52
1.0
2.1
—
—
—
0
0
24
188
1.28
0.51
1.2
1.5
—
—
—
0
0
118
1068
1.11
0.51
1.3
1.4
—
—
—
0
0
9
65
1.39
0.50
1.0
2.1
—
—
—
0
0
7
45
1.56
0.49
1.1
1.1
—
—
—
0
0
24
190
1.27
0.48
1.3
1.5
—
—
—
0
0
13
95
1.37
0.43
1.2
1.2
—
—
—
0
0
181
1936
0.93
0.42
1.2
1.2
17.7
12.8
u/ml
0.23
45
707
6
93
0.64
0.42
1.3
3.4
13.1
13.2
%
—
6
93
5
32
1.56
0.42
1.0
1.0
—
—
—
0
0
5
32
1.56
0.42
1.4
1.3
124.6
107.5
%
—
5
26
34
286
1.19
0.41
1.2
1.1
—
—
—
0
0
8
58
1.38
0.41
1.1
1.0
—
—
—
0
0
151
1402
1.09
0.41
2.2
2.5
6.3
7.6
ug/l
0.32
135
1251
5
33
1.52
0.41
1.0
1.3
—
—
—
0
0
0
15
0.00
0.41
0.0
1.5
—
—
—
0
0
46
398
1.16
0.41
1.7
1.6
0.7
16.5
iu/ml
—
5
73
0
16
0.00
0.41
0.0
1.4
—
18.1
—
0
16
10
138
0.72
0.40
1.5
1.7
—
—
—
0
0
40
343
1.17
0.40
5.8
3.3
1.4
1.6
mmol/l
0.79
40
336
8
61
1.31
0.39
1.1
1.2
—
—
—
0
0
65
581
1.12
0.38
1.4
1.9
37.8
38.6
u/l
0.12
54
501
36
418
0.86
0.37
2.1
1.7
—
—
—
0
0
35
300
1.17
0.36
2.1
1.6
0.9
0.8
nmol/l
0.41
30
245
193
1831
1.06
0.32
4.4
4.8
30.3
32.5
%
2.12
136
1194
10
75
1.34
0.30
1.2
1.4
—
—
—
0
0
10
75
1.34
0.30
1.2
1.4
—
—
—
0
0
11
84
1.31
0.30
1.0
1.9
—
—
—
0
0
11
84
1.31
0.30
1.0
1.9
—
—
—
0
0
11
84
1.31
0.30
1.0
1.9
—
—
—
0
0
11
84
1.31
0.30
1.0
1.9
—
—
—
0
0
212
2025
1.05
0.28
1.2
1.3
39.7
37.6
iu/ml
0.06
64
645
12
95
1.27
0.26
1.4
1.4
—
—
—
0
0
19
160
1.19
0.25
1.3
1.5
—
—
—
0
0
22
188
1.17
0.25
1.3
1.5
—
—
—
0
0
22
188
1.17
0.25
1.3
1.5
—
—
—
0
0
15
123
1.22
0.25
1.1
1.1
—
40.0
—
0
5
1339
13302
1.05
0.25
5.2
5.4
2.6
2.6
mmol/l
2.99
1194
12102
17
142
1.20
0.24
1.2
1.7
—
—
—
0
0
17
142
1.20
0.24
1.2
1.7
—
—
—
0
0
17
142
1.20
0.24
1.2
1.7
—
—
—
0
0
12
96
1.25
0.24
1.4
2.1
517.6
710.3
e6/l
—
5
42
11
87
1.27
0.24
1.5
1.1
60.3
46.6
mg/l
0.40
11
77
22
189
1.17
0.24
1.3
1.5
—
—
—
0
0
1299
12900
1.04
0.23
4.7
4.7
1.3
1.4
mmol/l
23.44
1162
11718
5
38
1.32
0.23
1.6
1.1
—
—
—
0
0
11
88
1.25
0.22
1.3
1.1
—
—
—
0
0
5
40
1.25
0.22
1.0
1.1
—
—
—
0
0
37
333
1.11
0.22
1.1
1.2
3.7
4.3
u/ml
—
7
44
20
172
1.16
0.22
1.2
1.2
3.1
4.8
u/ml
—
7
60
5
42
1.19
0.21
1.4
2.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
12
144
0.83
0.20
2.0
1.4
78834.3
85438.5
e6/l
—
7
100
17
146
1.17
0.19
1.2
1.1
—
—
—
0
0
1308
13006
1.04
0.19
4.8
4.8
4.4
4.5
mmol/l
4.02
1185
11909
541
5316
1.03
0.19
4.3
4.5
22.9
21.5
%
1.48
285
2682
21
185
1.14
0.18
1.6
1.4
—
—
—
0
0
5
66
0.76
0.17
1.2
1.1
—
—
—
0
0
31
283
1.10
0.16
1.3
1.3
—
—
—
0
0
1257
12502
1.03
0.15
4.2
4.3
1.5
1.3
mmol/l
13.65
1121
11263
19
168
1.13
0.15
1.2
1.2
4.6
5.7
u/ml
—
9
81
49
458
1.07
0.15
1.3
1.5
—
—
—
0
0
9
80
1.13
0.15
1.3
1.0
—
—
—
0
0
9
110
0.82
0.13
1.4
1.7
—
—
—
0
0
18
161
1.12
0.13
1.0
1.1
—
—
—
0
0
10
85
1.18
0.12
1.3
1.1
378.3
306.1
mg/l
—
10
77
32
297
1.08
0.12
1.5
1.4
919.1
720.8
e6/l
0.09
24
238
32
297
1.08
0.12
1.5
1.3
98.7
41.5
e6/l
0.26
24
231
53
502
1.06
0.12
1.1
1.3
—
—
—
0
0
136
1399
0.97
0.11
1.6
1.8
1.5
1.6
%
1.27
115
1185
10
86
1.16
0.11
3.5
4.0
—
—
—
0
0
388
3829
1.02
0.10
3.1
3.1
0.9
0.7
ug/l
2.29
293
2619
6
58
1.03
0.08
1.0
1.1
—
—
—
0
0
37
389
0.95
0.08
1.9
1.7
13483.1
16648.8
e6/l
0.26
26
279
6
74
0.81
0.07
3.0
3.5
—
—
—
0
0
9
84
1.07
0.07
1.6
1.4
—
64.5
—
0
11
11
122
0.90
0.07
1.0
1.0
—
—
—
0
0
17
179
0.95
0.03
1.1
1.0
—
—
—
0
0
50
510
0.98
0.02
1.3
1.6
—
—
—
0
0
48
489
0.98
0.02
1.0
1.0
—
—
—
0
0
34
347
0.98
0.01
2.7
3.2
0.8
0.8
nmol/l
0.14
28
269
0
5
0.00
0.00
0.0
1.0
—
7.7
—
0
5
0
5
0.00
0.00
0.0
8.0
—
74.8
—
0
5
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
5
56
0.89
0.00
1.0
1.5
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
5
53
0.94
0.00
1.2
1.2
368.2
224.1
iu/ml
—
5
53
0
7
0.00
0.00
0.0
1.4
—
2.1
—
0
7
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_KIDNEY_CLEAR_CELL_CARCINOMA – Clear cell adenocarcinoma of kidney
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).